We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+19.76%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$26.7B
AUM Growth
+$4.09B
(+18%)
Cap. Flow
+$629M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
1,469
New
391
Increased
391
Reduced
480
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$169M |
| 2 |
NVIDIA
NVDA
|
+$154M |
| 3 |
ServiceNow
NOW
|
+$132M |
| 4 |
GE Aerospace
GE
|
+$129M |
| 5 |
Cintas
CTAS
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Motorola Solutions
MSI
|
+$134M |
| 2 |
Cisco
CSCO
|
+$112M |
| 3 |
US Bancorp
USB
|
+$109M |
| 4 |
Amazon
AMZN
|
+$106M |
| 5 |
Ross Stores
ROST
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.4% |
| 2 | Communication Services | 13.42% |
| 3 | Financials | 12.75% |
| 4 | Healthcare | 10.61% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Tango Therapeutics
TNGX
$4.32B
| $52.7K | ﹤0.01% |
10,290
-118,820
| -92% | -$294K |
|
1302
Cytek Biosciences
CTKB
$636M
| $52.1K | ﹤0.01% |
+15,332
| New | +$51.1K |
|
1303
Definitive Healthcare
DH
$68.4M
| $51.1K | ﹤0.01% |
+13,110
| New | +$41.3K |
|
1304
Voyager Therapeutics
VYGR
$198M
| $50.3K | ﹤0.01% |
+16,180
| New | +$52.2K |
|
1305
Annexon
ANNX
$862M
| $48.5K | ﹤0.01% |
+20,196
| New | +$40.5K |
|
1306
Geron
GERN
$982M
| $48.2K | ﹤0.01% |
34,174
| – | – |
|
1307
Siebert Financial
SIEB
$78.1M
| $47.6K | ﹤0.01% |
+10,760
| New | +$43.7K |
|
|
ESPR
1308
DELISTED
Esperion Therapeutics
ESPR
| $47.4K | ﹤0.01% |
48,172
| – | – |
|
1309
Holley
HLLY
$362M
| $47.2K | ﹤0.01% |
+23,580
| New | +$50K |
|
1310
Protara Therapeutics
TARA
$233M
| $47.1K | ﹤0.01% |
+15,545
| New | +$53.6K |
|
1311
Vaalco Energy
EGY
$592M
| $46.5K | ﹤0.01% |
12,870
-84,620
| -87% | -$294K |
|
|
YMAB
1312
DELISTED
Y-mAbs Therapeutics
YMAB
| $46.4K | ﹤0.01% |
+10,284
| New | +$46.2K |
|
1313
loanDepot
LDI
$320M
| $46.3K | ﹤0.01% |
+36,450
| New | +$44.6K |
|
|
CRGX
1314
DELISTED
CARGO Therapeutics
CRGX
| $45.9K | ﹤0.01% |
+11,150
| New | +$47.8K |
|
1315
Erasca
ERAS
$6.25B
| $44.5K | ﹤0.01% |
+35,075
| New | +$47K |
|
1316
Design Therapeutics
DSGN
$901M
| $42.9K | ﹤0.01% |
+12,735
| New | +$47.7K |
|
1317
4D Molecular Therapeutics
FDMT
$609M
| $41.8K | ﹤0.01% |
+11,280
| New | +$39.7K |
|
1318
Allogene Therapeutics
ALLO
$683M
| $40.6K | ﹤0.01% |
+35,970
| New | +$47.8K |
|
1319
Agilon Health
AGL
$1.49B
| $37.3K | ﹤0.01% |
649
-4,570
| -88% | -$367K |
|
1320
American Airlines Group
AAL
$9.97B
| – | – |
-64,866
| Closed | -$684K |
|
1321
Accel Entertainment
ACEL
$1.01B
| – | – |
-19,175
| Closed | -$190K |
|
1322
Albertsons Companies
ACI
$6.02B
| – | – |
-74,820
| Closed | -$1.65M |
|
1323
ADT
ADT
$5.46B
| – | – |
-57,954
| Closed | -$472K |
|
1324
AES
AES
$10.5B
| – | – |
-153,215
| Closed | -$1.9M |
|
|
AFCG
1325
AFC Gamma
AFCG
$68.7M
| – | – |
-42,758
| Closed | -$238K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Los Angeles Capital Management held 1,469 positions worth $26.7B, up 18% from $22.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Los Angeles Capital Management's Q2 2025 filing shows 391 new, 391 increased, 480 reduced and 149 closed positions. Its largest new stake was HEICO Corp: 221,412 shares worth $72.6M. The largest sale was Motorola Solutions, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Communication Services and Financials.
- Los Angeles Capital Management's largest Q2 2025 buy was HEICO Corp: 221,412 shares worth $72.6M.
- Los Angeles Capital Management added most to Veeva Systems in Q2 2025, an estimated $169M increase.
- Los Angeles Capital Management's biggest Q2 2025 reduction was Motorola Solutions, cutting an estimated $134M.
- Los Angeles Capital Management fully exited Discover Financial Services in Q2 2025, selling an estimated $50.3M.
- Los Angeles Capital Management's ten largest holdings make up 39% of its $26.7B portfolio in Q2 2025.
- Los Angeles Capital Management opened 391 new positions and closed 149 in Q2 2025.
- Los Angeles Capital Management's portfolio value rose 18% quarter-over-quarter to $26.7B.
Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.